FTC would review a new Merck/Sanofi-Aventis JV

Drug makers Sanofi-Aventis and Merck are expected to reignite their animal-health joint venture in the coming weeks, exposing the companies to a fresh round of antitrust scrutiny by the US Federal Trade Commission.

Purchase an approved for publication custom PDF below.

An official PDF provides excellent marketing opportunities, enabling you to post the article online, make reprints and distribute under the GCR brand.

• £100 (GBP)
Add Amount: 1 2 3 4 5 6 7 8 9 10
• Add to Basket